Sex Differences in Blood Pressure–Lowering Therapy and Outcomes Following Intracerebral Hemorrhage: Results From ATACH-2. Issue 8 (August 2020)

• Record Type: Journal Article
• Authors: Fukuda-Doi, Mayumi; Yamamoto, Haruko; Koga, Masatoshi; Palesch, Yuko Y.; Durkalski-Mauldin, Valerie L.; Qureshi, Adnan I.; Yoshimura, Sohei; Okazaki, Shuhei; Miwa, Kaori; Okada, Yasushi; Ueda, Toshihiro; Okuda, Satoshi; Nakahara, Jin; Suzuki, Norihiro; Toyoda, Kazunori
• Is Part Of: Stroke. Volume 51:Issue 8(2020)
• Publication Date: 2020-08
• Subjects: blood pressure -- cerebral hemorrhage -- clinical trial -- hematoma -- sex; Cerebrovascular disease -- Periodicals; Cerebral circulation -- Periodicals; 616.81
• DOI: 10.1161/STROKEAHA.120.029770
• Languages: English
• ISSNs: 0039-2499

Abstract

Abstract : Background and Purpose: Evidence regarding sex differences in clinical outcomes and treatment effect following intracerebral hemorrhage is limited. Using the ATACH-2 trial (Antihypertensive Treatment in Intracerebral Hemorrhage-2) data, we explored whether sex disparities exist in outcomes and response to intensive blood pressure (BP)–lowering therapy. Methods: Eligible intracerebral hemorrhage subjects were randomly assigned to intensive (target systolic BP, 110–139 mm Hg) or standard (140–179 mm Hg) BP-lowering therapy within 4.5 hours after onset. Relative risk of death or disability corresponding to the modified Rankin Scale score of 4 to 6 was calculated, and interaction between sex and treatment was explored. Results: In total, 380 women and 620 men were included. Women were older, more prescribed antihypertensive drugs before onset, and had more lobar intracerebral hemorrhage than men. Hematoma expansion was observed less in women. After multivariable adjustment, the relative risk of death or disability in women was 1.19 (95% CI, 1.02–1.37, P =0.023). The relative risk of death or disability between intensive versus standard BP-lowering therapy was 0.91 (95% CI, 0.74–1.13) in women versus 1.13 (95% CI, 0.92–1.39) in men ( P for interaction=0.11), with inconclusive Gail-Simmon test ( P =0.16). Conclusions: Women had a higher risk of death or disability following intracerebral hemorrhage. The benefit of intensive BP-lowering therapy in women is inconclusive, consistent with the overall results of ATACH-2. Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT01176565. Abstract : Supplemental Digital Content is available in the text.